By Jon Hill ( August 1, 2017, 9:15 PM EDT) -- The U.S. Securities and Exchange Commission has upheld an in-house judge's decision to revoke the registration of an Illinois biopharmaceutical company's securities, saying the value of its antibiotic research does not justify a lesser penalty for its failure to file a quarterly or annual report in more than six years....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.